FIELD: chemistry.
SUBSTANCE: invention relates to biochemistry, particularly to an immunoconjugate for treating GD2-positive oncological diseases. Also disclosed is a composition containing said immunoconjugate. Disclosed is a method of treating a GD2-specific tumor disease using said immunoconjugate.
EFFECT: invention provides effective treatment of diseases associated with GD2.
9 cl, 8 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-CD79B ANTIBODIES, IMMUNOCONJUGATES AND METHODS FOR THEIR USE | 2019 |
|
RU2791984C2 |
| GD2 BINDING MOLECULE | 2020 |
|
RU2824670C2 |
| MULTI-SPECIFIC ANTIBODIES AND METHODS OF THEIR PRODUCTION AND USE | 2018 |
|
RU2811477C2 |
| ANTI-c-MET DRUG CONJUGATE AND USE THEREOF | 2021 |
|
RU2822497C1 |
| ANTIBODIES AGAINST FOLIC ACID RECEPTOR 1, THEIR IMMUNOCONJUGATES AND USE | 2011 |
|
RU2740479C2 |
| USE OF THE ANTI-O-ACETYLATED GANGLIOSIDE GD2 ANTIBODY FOR IMPROVING THE THERAPEUTIC POTENTIAL OF DRUGS | 2017 |
|
RU2771173C2 |
| METHODS FOR PREPARING ANTIBODY-DRUG CONJUGATE COMPOSITIONS | 2015 |
|
RU2741470C2 |
| ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION | 2016 |
|
RU2757815C2 |
| COMPOSITIONS OF ANTIBODIES AGAINST ROR1 AND CORRESPONDING METHODS | 2017 |
|
RU2766190C2 |
| NEW ANTI-CD19 ANTIBODIES | 2018 |
|
RU2791445C2 |
